恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013 
恒瑞医药(600276) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入1,701,363.221,116,837.90549,232.012,127,527.071,594,530.54
营业收入1,701,363.221,116,837.90549,232.012,127,527.071,594,530.54
二、营业总成本1,325,878.67872,880.61420,640.231,774,708.431,256,917.74
营业成本265,755.41176,937.2285,951.71348,663.89266,874.81
营业税金及附加16,273.3210,960.775,095.4719,038.8714,392.15
销售费用540,855.13367,844.60166,975.69734,789.31516,169.59
管理费用167,591.25108,392.0954,567.10230,647.80146,830.52
财务费用-37,145.93-24,382.12-6,833.69-47,086.71-37,103.18
研发费用372,549.50233,128.05114,883.95488,655.27349,753.86
资产减值损失----------
公允价值变动收益-3,576.83-2,762.30-378.657,650.25-161.71
投资收益-1,156.57-955.833,310.5038,736.4610,740.93
其中:对联营企业和合营企业的投资收益-4,711.47-4,180.45---6,299.55--
汇兑收益----------
三、营业利润394,132.95257,020.94134,443.01411,196.00365,183.23
加:营业外收入243.48161.3342.81208.17140.33
减:营业外支出13,138.745,937.752,010.9514,554.9611,924.29
其中:非流动资产处置损失----------
四、利润总额381,237.69251,244.52132,474.87396,849.21353,399.27
减:所得税费用36,134.7122,203.939,135.6215,342.1243,794.61
五、净利润345,102.98229,040.58123,339.25381,507.09309,604.66
归属于母公司所有者的净利润347,377.92230,826.50123,910.75390,630.44317,338.99
少数股东损益-2,274.93-1,785.92-571.50-9,123.35-7,734.33
六、每股收益
基本每股收益(元/股)0.55000.36000.19000.61000.5000
稀释每股收益(元/股)0.55000.36000.19000.61000.5000
七、其他综合收益1,400.442,251.32-1,968.601,586.88-663.05
八、综合收益总额346,503.42231,291.90121,370.64383,093.97308,941.61
归属于母公司所有者的综合收益总额348,469.65232,700.91122,078.04392,107.55316,593.12
归属于少数股东的综合收益总额-1,966.24-1,409.01-707.39-9,013.58-7,651.51
下载全部历史数据到excel中 返回页顶